IL-11 Protects Human Microvascular Endothelium from Alloinjury In Vivo by Induction of Survivin Expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-11 Protects Human Microvascular Endothelium from Alloinjury In Vivo by Induction of Survivin Expression

Published:2004-01-20 Issue:3 Volume:172 Page:1391-1396
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Kirkiles-Smith Nancy C.,Mahboubi Keyvan,Plescia Janet,McNiff Jennifer M.,Karras James,Schechner Jeffrey S.,Altieri Dario C.,Pober Jordan S.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response.

2. Renal target structures in acute allograft rejection: A histochemical study

3. EVIDENCE THAT PORTAL TRACT MICROVASCULAR DESTRUCTION PRECEDES BILE DUCT LOSS IN HUMAN LIVER ALLOGRAFT REJECTION

4. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse.

5. Dermal Microvascular Injury in the Human Peripheral Blood Lymphocyte Reconstituted-Severe Combined Immunodeficient (HuPBL-SCID) Mouse/Skin Allograft Model Is T Cell Mediated and Inhibited by a Combination of Cyclosporine and Rapamycin

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. H3K9 lactylation in malignant cells facilitates CD8+ T cell dysfunction and poor immunotherapy response;Cell Reports;2024-09

2. Harnessing the regenerative potential ofinterleukin11to enhance heart repair;2024-01-30

3. Roles and mechanism of IL-11 in vascular diseases;Frontiers in Cardiovascular Medicine;2023-05-26

4. Tetrac as an anti-angiogenic agent in cancer;Endocrine-Related Cancer;2019-06

5. Regulation of human T cell responses by dNP2-ctCTLA-4 inhibits human skin and microvessel graft rejection;Biomaterials;2018-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3